pd-1 inhibitor pembrolizumab shows promising clinical activity for triple-negative breast cancer
Published 9 years ago • 1K plays • Length 6:10Download video MP4
Download video MP3
Similar videos
-
7:38
pembrolizumab shows promising activity against head and neck cancer
-
3:26
pd-1 therapy with eribulin for triple negative mbc
-
5:25
investigational pd-l1–targeted immunotherapy safe for patients with triple-negative breast cancer
-
1:30
emerging immunotherapy beyond checkpoint inhibitors for tnbc
-
12:45
keynote-355: first-line pembrolizumab plus chemotherapy for metastatic triple-negative breast ca...
-
4:54
keynote-522 updates: pembrolizumab plus neoadjuvant chemotherapy in early triple-negative breast...
-
20:43
investigational pd-l1–targeted immunotherapy safe for patients with triple-negative breast cancer
-
1:42
checkpoint inhibitors for triple-negative breast cancer
-
10:14
asco: pembrolizumab plus chemotherapy for advanced triple-negative breast cancer
-
5:49
immunotherapy for tnbc
-
2:21
new study identifies promising drug combinations for triple negative breast cancer treatment
-
3:21
promising clinical trial for triple-negative breast cancer patients
-
9:00
immunotherapy shows early promise for patients with trastuzumab-resistant breast cancer
-
1:58
promising novel approaches to the treatment of tnbc
-
1:03
new directions in immunotherapy for improving outcomes in tnbc
-
2:21
new treatment shows promise for triple-negative breast cancer patients
-
1:08
neoadjuvant durvalumab shows benefit in triple-negative breast cancer
-
0:37
pembrolizumab shows promise for advanced esophageal cancers
-
0:59
impassion130 data demonstrate clinical benefit for immunotherapy in metastatic tnbc